Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Cardiac | 11 | 2023 | 1637 | 0.730 |
Why?
|
Atrial Function, Left | 1 | 2020 | 173 | 0.690 |
Why?
|
Heart Atria | 5 | 2022 | 1357 | 0.570 |
Why?
|
Shal Potassium Channels | 2 | 2013 | 21 | 0.540 |
Why?
|
Kv Channel-Interacting Proteins | 2 | 2013 | 56 | 0.530 |
Why?
|
Adenine | 1 | 2020 | 936 | 0.520 |
Why?
|
Purkinje Fibers | 1 | 2013 | 32 | 0.460 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2013 | 88 | 0.440 |
Why?
|
Piperidines | 1 | 2020 | 1602 | 0.420 |
Why?
|
Potassium Channel Blockers | 2 | 2013 | 171 | 0.420 |
Why?
|
Potassium Channels | 2 | 2013 | 563 | 0.380 |
Why?
|
Ventricular Fibrillation | 1 | 2013 | 538 | 0.360 |
Why?
|
NFATC Transcription Factors | 4 | 2014 | 381 | 0.350 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2021 | 173 | 0.340 |
Why?
|
Heart Rate | 1 | 2020 | 4091 | 0.340 |
Why?
|
Protein Kinase Inhibitors | 4 | 2021 | 5535 | 0.340 |
Why?
|
Atrial Fibrillation | 5 | 2022 | 5034 | 0.330 |
Why?
|
Phenethylamines | 1 | 2008 | 96 | 0.320 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2008 | 104 | 0.320 |
Why?
|
Calcium Signaling | 2 | 2008 | 721 | 0.290 |
Why?
|
Tachycardia | 1 | 2008 | 619 | 0.270 |
Why?
|
Calcium | 5 | 2021 | 5756 | 0.270 |
Why?
|
Sulfonamides | 3 | 2018 | 1938 | 0.260 |
Why?
|
Dogs | 6 | 2013 | 3912 | 0.240 |
Why?
|
Electronics | 1 | 2023 | 322 | 0.200 |
Why?
|
Cell Aggregation | 1 | 2021 | 244 | 0.200 |
Why?
|
Barth Syndrome | 1 | 2021 | 25 | 0.190 |
Why?
|
Leukemia, B-Cell | 1 | 2021 | 86 | 0.190 |
Why?
|
Biology | 1 | 2023 | 294 | 0.190 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13695 | 0.190 |
Why?
|
Mice, Inbred CBA | 1 | 2020 | 448 | 0.180 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4462 | 0.180 |
Why?
|
Mice, 129 Strain | 1 | 2020 | 386 | 0.180 |
Why?
|
Heart Conduction System | 3 | 2017 | 1047 | 0.170 |
Why?
|
Cell Nucleus | 1 | 2008 | 2969 | 0.170 |
Why?
|
Indole Alkaloids | 1 | 2018 | 24 | 0.170 |
Why?
|
Up-Regulation | 1 | 2008 | 4217 | 0.170 |
Why?
|
Action Potentials | 5 | 2020 | 1806 | 0.160 |
Why?
|
Myocardium | 2 | 2008 | 4776 | 0.160 |
Why?
|
Aminoquinolines | 1 | 2018 | 109 | 0.160 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 424 | 0.150 |
Why?
|
Coculture Techniques | 1 | 2021 | 1341 | 0.150 |
Why?
|
Mitochondria, Heart | 1 | 2018 | 247 | 0.140 |
Why?
|
Disulfides | 1 | 2018 | 457 | 0.140 |
Why?
|
Arrhythmias, Cardiac | 3 | 2021 | 2268 | 0.140 |
Why?
|
Patch-Clamp Techniques | 3 | 2014 | 964 | 0.130 |
Why?
|
Cells, Cultured | 7 | 2017 | 19229 | 0.130 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2012 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.120 |
Why?
|
Heart Ventricles | 4 | 2013 | 3821 | 0.120 |
Why?
|
Delayed Rectifier Potassium Channels | 1 | 2014 | 3 | 0.120 |
Why?
|
Calcineurin | 3 | 2014 | 226 | 0.120 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2023 | 1736 | 0.120 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2014 | 51 | 0.120 |
Why?
|
Immediate-Early Proteins | 1 | 2017 | 453 | 0.120 |
Why?
|
Potassium | 4 | 2014 | 1336 | 0.120 |
Why?
|
Isoproterenol | 1 | 2014 | 399 | 0.120 |
Why?
|
Tetraethylammonium | 1 | 2013 | 58 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1783 | 0.110 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2077 | 0.110 |
Why?
|
Adrenergic beta-Agonists | 1 | 2014 | 346 | 0.110 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2013 | 150 | 0.110 |
Why?
|
Ion Channel Gating | 1 | 2014 | 437 | 0.100 |
Why?
|
Cricetulus | 1 | 2013 | 816 | 0.100 |
Why?
|
Cardiac Pacing, Artificial | 3 | 2009 | 845 | 0.090 |
Why?
|
Calcium Channels, L-Type | 2 | 2009 | 240 | 0.090 |
Why?
|
Sodium | 2 | 2022 | 1623 | 0.090 |
Why?
|
CHO Cells | 1 | 2013 | 1406 | 0.090 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3798 | 0.090 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 581 | 0.090 |
Why?
|
Animals | 15 | 2022 | 168757 | 0.090 |
Why?
|
Long QT Syndrome | 2 | 2015 | 453 | 0.090 |
Why?
|
Cricetinae | 1 | 2013 | 2472 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 21827 | 0.080 |
Why?
|
Mice, Knockout | 2 | 2021 | 14557 | 0.080 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2008 | 91 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2023 | 11483 | 0.080 |
Why?
|
Calcium Channel Blockers | 2 | 2008 | 690 | 0.080 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2008 | 158 | 0.080 |
Why?
|
Torsades de Pointes | 1 | 2009 | 78 | 0.080 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.080 |
Why?
|
Estradiol | 1 | 2015 | 2020 | 0.080 |
Why?
|
Ion Transport | 1 | 2008 | 320 | 0.070 |
Why?
|
Bradycardia | 1 | 2009 | 307 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2899 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2008 | 443 | 0.070 |
Why?
|
Tachycardia, Supraventricular | 1 | 2008 | 263 | 0.070 |
Why?
|
Transfection | 1 | 2013 | 5892 | 0.060 |
Why?
|
MicroRNAs | 2 | 2013 | 3752 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18029 | 0.060 |
Why?
|
Ion Channels | 1 | 2008 | 1056 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2008 | 1081 | 0.060 |
Why?
|
Muscle Proteins | 1 | 2008 | 1159 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12072 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5655 | 0.050 |
Why?
|
Egtazic Acid | 2 | 2014 | 173 | 0.050 |
Why?
|
Retinal Dehydrogenase | 1 | 2021 | 74 | 0.050 |
Why?
|
Genes, Wilms Tumor | 1 | 2021 | 94 | 0.050 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2021 | 162 | 0.050 |
Why?
|
Semaphorins | 1 | 2021 | 101 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2013 | 3589 | 0.050 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2021 | 271 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23338 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2021 | 471 | 0.040 |
Why?
|
Mesoderm | 1 | 2021 | 686 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 664 | 0.040 |
Why?
|
Humans | 14 | 2023 | 744343 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2021 | 687 | 0.040 |
Why?
|
Phosphorylation | 1 | 2008 | 8436 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3505 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 481 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2008 | 13033 | 0.030 |
Why?
|
Connexin 43 | 1 | 2017 | 207 | 0.030 |
Why?
|
Clomiphene | 1 | 2015 | 72 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15165 | 0.030 |
Why?
|
Fertility Agents, Female | 1 | 2015 | 99 | 0.030 |
Why?
|
Benzoquinones | 1 | 2015 | 201 | 0.030 |
Why?
|
Heart Failure | 2 | 2008 | 10900 | 0.030 |
Why?
|
Glycolysis | 1 | 2018 | 827 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2015 | 320 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 72290 | 0.030 |
Why?
|
Propanolamines | 1 | 2014 | 167 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 2014 | 206 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2017 | 627 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2107 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2183 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2014 | 1386 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 2025 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 2015 | 551 | 0.030 |
Why?
|
Mice | 4 | 2022 | 81183 | 0.030 |
Why?
|
Chromatin | 1 | 2023 | 2934 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1912 | 0.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 500 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2014 | 1472 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Protein Transport | 1 | 2015 | 1988 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.020 |
Why?
|
Infertility, Female | 1 | 2015 | 787 | 0.020 |
Why?
|
Nimodipine | 1 | 2008 | 55 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2804 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2014 | 859 | 0.020 |
Why?
|
Stem Cells | 1 | 2021 | 3567 | 0.020 |
Why?
|
Calmodulin | 1 | 2008 | 209 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1206 | 0.020 |
Why?
|
Atrioventricular Block | 1 | 2009 | 120 | 0.020 |
Why?
|
Chelating Agents | 1 | 2008 | 380 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7722 | 0.020 |
Why?
|
Sodium Channels | 1 | 2008 | 349 | 0.020 |
Why?
|
Male | 5 | 2018 | 350118 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 2564 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 514 | 0.020 |
Why?
|
Zebrafish | 1 | 2017 | 2994 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 3002 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2889 | 0.020 |
Why?
|
Calcium Channels | 1 | 2008 | 622 | 0.020 |
Why?
|
Tacrolimus | 1 | 2008 | 743 | 0.020 |
Why?
|
Female | 5 | 2017 | 380194 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15997 | 0.010 |
Why?
|
Binding Sites | 1 | 2013 | 6114 | 0.010 |
Why?
|
Renin-Angiotensin System | 1 | 2008 | 759 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2009 | 1585 | 0.010 |
Why?
|
Middle Aged | 2 | 2017 | 213383 | 0.010 |
Why?
|
Cell Death | 1 | 2008 | 1706 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4894 | 0.010 |
Why?
|
Adult | 2 | 2015 | 214055 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6442 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 1312 | 0.010 |
Why?
|
Fibrosis | 1 | 2008 | 2029 | 0.010 |
Why?
|
Hypertension | 1 | 2021 | 8480 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3340 | 0.010 |
Why?
|
Time Factors | 2 | 2008 | 40075 | 0.010 |
Why?
|
Rats | 1 | 2013 | 24260 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53288 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 29786 | 0.010 |
Why?
|
Prognosis | 1 | 2008 | 29063 | 0.000 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_